Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-25-284976·COLUMN GROUP II, LP
Schedule 13G ownership disclosure
ORIC Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 68622P109
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- The Column Group II, LP
Shares: 3,540,777 · Class: 3.6%
- The Column Group II GP, LP
Shares: 3,540,777 · Class: 3.6%
- David V Goeddel
Shares: 3,627,493 · Class: 3.7%
- Peter Svennilson
Shares: 3,644,118 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-284976
- Form type
- SCHEDULE 13G/A
- Filer
- COLUMN GROUP II, LP
- CIK
- CIK 1600420
- Filed
- Nov 17, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership